Severe ulceration over mandibular torus in an ovarian cancer patient receiving bevacizumab therapy.

► Bevacizumab may increase the risk of mucosal ulceration and subsequent bone necrosis. ► Patients receiving bevacizumab should be closely monitored for dental symptoms.